Rhinitis Allergic, Persistent Clinical Trial
Official title:
Long-term Evaluation of Safety and Treatment Satisfaction With Levocetirizine in Routine Clinical Practice in the Czech and Slovak Republics - Non-interventional Study
To evaluate over a period of 6 months the safety and the treatment satisfaction of newly prescribed levocetirizine in patients of age ≥ 2 years with persistent allergic rhinitis.
This is a non-interventional, prospective, post-authorization, multi-centre cohort study in
patients treated with levocetirizine.
The baseline data will be collected at the visit to the physician when levocetirizine is
prescribed for the first time for the patient for Persistent Allergic Rhinitis. The data
will then be collected during 2 visits occurring within the first 6 months of treatment, as
usually scheduled in normal clinical practice in the Czech and Slovak Republics. This is
after approximately 4 weeks and 6 months of treatment or earlier, if the treatment is
stopped
;
Observational Model: Cohort, Time Perspective: Prospective